JUN 19, 2017 3:22 PM PDT

Human Stem Cell Descendants: Drugs of the Future

WRITTEN BY: Kara Marker

Immune cells, like all cells of the human body, come from less-specific ancestor cells, sometimes called progenitor cells or stem cells, creating a family tree of sorts that resembles family trees we’re familiar with, decked with mothers and fathers, aunts and uncles, and other distant relatives. A new study from Tokyo Medical and Dental University (TMDU) is focused on understanding the birth of immune cell lineages, holding that this knowledge is the key to new protection from pathogens.

There are certain human stem cells, undifferentiated cells with the ability to become any cell type, that scientists believe are “destined” to become specific immune cells, called monocytes. Monocytes, produced by a common monocyte progenitor cell (cMoP), are precursors to specialized immune cells like macrophages and dendritic cells, which serve the immune system by engulfing pathogens and recognizing chemical signals expressed by pathogenic cells, respectively. However, monocytes also serve as a precursor to cells associated with disease, including tumor-associated macrophages, osteoclasts, and colitogenic macrophages. This makes monocytes a clear target in certain contexts.

Monocytes differentiate into macrophages and dendritic cells based on inflammatory signals that send messages about what the immune system needs most. Researchers first identified the precursor to monocytes, cMoPs, in mice, but now these ancestor cells have also but identified in humans.

Identification of human common monocyte progenitor (cMoP). Credit: Tokyo Medical and Dental University

How are certain monocytes created? How could scientists target cMoPs to increase the amount of monocytes produced to boost the immune response? How could scientists target cMoPs to decrease the amount of monocytes to prevent aiding diseases like cancer? Researchers from TMDU were and are devoted to answering these questions. In their study, the screened all of the unique proteins displayed by monocytes, macrophages, and dendritic cells, to distinguish how their expression influenced differentiation. Two proteins, CLEC12A and CD64, were found to mark the difference between high and low expression levels.

TMDU researchers created four subgroups according to expression levels of CLEC12A and CD64. For example, stem cells expressing high levels of CLEC12A and CD64 only differentiated into monocytes, suggested that these stem cells were the cMoPs previously identified in mice. High levels of CLEC12A and intermediate expression of CD64 instead led to granulocyte and monocyte differentiation. Those groups with no CD64 expression at all resulted in dendritic cells only.

"Focusing on the expression level and pattern of cell surface proteins, we observed a sequential differentiation process from granulocyte/monocyte progenitors via cMoPs to pre-monocytes then monocytes that was supported by gene expression studies," corresponding author Toshiaki Ohteki says. "This updates what we know about the human blood cell developmental pathway."

While the work of Ohteki and the TMDU research team seems far away from being applied to a treatment useful in the clinic, their research provides the sturdy scientific foundation needed for anti-cancer and anti-infection therapies of the future, those that defy all limitations as we know them.

The present study was published in the journal Immunity.

Source: Tokyo Medical and Dental University

 

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 05, 2020
Cancer
Does Having an Appendectomy Increase Your Risk for Cancer?
OCT 05, 2020
Does Having an Appendectomy Increase Your Risk for Cancer?
Cancer research is more than just the study of diagnostics and novel therapies. Researchers also investigate the causes ...
OCT 05, 2020
Cell & Molecular Biology
Gaining Insight Into the Connection Between Depression and Stress
OCT 05, 2020
Gaining Insight Into the Connection Between Depression and Stress
Depression is a common mental illness, and stress is known to be an environmental influence that can increase the risk o ...
OCT 15, 2020
Cardiology
Measuring Pulse Transit Time as a Replacement for the Inflatable Cuff
OCT 15, 2020
Measuring Pulse Transit Time as a Replacement for the Inflatable Cuff
Many people deal with one disease or another every day of their life. Most require checking on things like blood sugar f ...
OCT 18, 2020
Cardiology
Many Heart Disease Deaths Are Preventable With Diet Improvements
OCT 18, 2020
Many Heart Disease Deaths Are Preventable With Diet Improvements
New research has suggested that over two-thirds of heart disease cases around the world are preventable with improvement ...
OCT 19, 2020
Genetics & Genomics
Early Childhood Trauma Affects Metabolism in the Next Generation
OCT 19, 2020
Early Childhood Trauma Affects Metabolism in the Next Generation
Traumatic experiences can have a lasting impact, and kids that suffer through them can feel the effects for a lifetime. ...
OCT 27, 2020
Cardiology
Boron Could Prevent Myocardial Fibrosis and Assist in Recovery
OCT 27, 2020
Boron Could Prevent Myocardial Fibrosis and Assist in Recovery
When you pass by the nutrition section at the local grocery store, there is a chance you’ll come across row upon r ...
Loading Comments...